I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Second-line FOLFOX chemotherapy versus active symptom contr..:
Lamarca, Angela
;
Palmer, Daniel H
;
Wasan, Harpreet Singh
...
The Lancet Oncology. 22 (2021) 5 - p. 690-701 , 2021
Link:
https://doi.org/10.1016/s1470-2045(21)00027-9
RT Journal T1
Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial
UL https://suche.suub.uni-bremen.de/peid=cr-10.1016_s1470-2045(21)00027-9&Exemplar=1&LAN=DE A1 Lamarca, Angela A1 Palmer, Daniel H A1 Wasan, Harpreet Singh A1 Ross, Paul J A1 Ma, Yuk Ting A1 Arora, Arvind A1 Falk, Stephen A1 Gillmore, Roopinder A1 Wadsley, Jonathan A1 Patel, Kinnari A1 Anthoney, Alan A1 Maraveyas, Anthony A1 Iveson, Tim A1 Waters, Justin S A1 Hobbs, Claire A1 Barber, Safia A1 Ryder, W David A1 Ramage, John A1 Davies, Linda M A1 Bridgewater, John A A1 Valle, Juan W PB Elsevier BV YR 2021 SN 1470-2045 JF The Lancet Oncology VO 22 IS 5 SP 690 OP 701 LK http://dx.doi.org/https://doi.org/10.1016/s1470-2045(21)00027-9 DO https://doi.org/10.1016/s1470-2045(21)00027-9 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)